NVSEF - Novartis AG (NVS) Presents at Cardiovascular Update Broker Conference Call - (Transcript)

Novartis AG (NVS) Cardiovascular Update Call May 18, 2021, 11:30 ET Company Participants Samir Shah - Global Head, IR David Soergel - Head, Cardiovascular, Renal & Metabolic Development Group Rod Wooten - Global Head, Marketing of Novartis Pharmaceuticals Victor Bulto - Head, US Pharmaceuticals Matthew Whitty - CEO of Accelerated Access Collaborative, NHS Group Conference Call Participants Laura Sutcliffe - UBS Keyur Parekh - Goldman Sachs Group Emmanuel Papadakis - Deutsche Bank Andrew Baum - Citigroup Graham Parry - Bank of America Merrill Lynch Jo Walton - Crédit Suisse Kerry Holford - Berenberg Florent Cespedes - Societe Generale Charles Pitman - Redburn Richard Parkes - Exane BNP Paribas Presentation Operator Good morning and good afternoon, and welcome to the Novartis cardiovascular update. [Operator Instructions]. With that, I would like to hand over to Mr. Samir Shah, Head of Investor Relations. Please go ahead, sir. Samir Shah Thank you, very much,

For further details see:

Novartis AG (NVS) Presents at Cardiovascular Update Broker Conference Call - (Transcript)